Using MRI scans to grade breast cancer and predict outlook
Part of Cancer, Skin clinical trials.
This study uses MRI scans to learn more about the tumor's grade and how the cancer might progress. It aims to help doctors predict outcomes and plan treatment better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed breast cancer diagnosis from a biopsy or surgery.
- You had a special MRI with contrast within 2 weeks before your surgery.
- You had not received any cancer treatment (like chemo or radiation) before that MRI.
- The tumor is larger than 5 millimeters.
- Your MRI images were clear and not affected by movement or missing data.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests advanced MRI imaging techniques to better diagnose breast cancer and evaluate treatment response. If you have a suspicious breast lesion, this trial may help doctors see it more clearly before biopsy or surgery.
This trial compares a special mammogram with dye (CEDM) to MRI for women already diagnosed with invasive breast cancer. The goal is to see if CEDM works as well as MRI for planning surgery, potentially offering a faster or easier option.
This study uses breast MRI scans to see whether neoadjuvant (before-surgery) chemotherapy is working. If you qualify, you’ll have MRI scans to help doctors understand how your breast cancer responds to standard treatment.
This study tests whether a new type of PET/MRI scan can help doctors see how well breast cancer treatment is working. It is a platform study, meaning it can evaluate different treatments, but the focus is on using this advanced imaging to monitor response.
This study is testing whether adding an MRI to a normal mammogram can find more cancers in women with dense breasts. If you participate, you may benefit from extra monitoring and peace of mind.
This study uses a special type of mammogram with contrast dye to see if it can predict how well breast cancer responds to chemotherapy before surgery. It's for people with HER2-positive or triple-negative breast cancer.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.